| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/03/2001 | US6210714 Immediate release tablet cores of acetaminophen having sustained-release coating |
| 04/03/2001 | US6210713 Oral delivery of discrete units |
| 04/03/2001 | US6210712 First or interior coat consisting of ethylcellulose and hydroxypropyl cellulose shielded by a second or exterior coat consisting of poly(cellulose acylate) from the environment of the gastrointestinal tract. |
| 04/03/2001 | US6210711 Effervescent microspheres and method for making them |
| 04/03/2001 | US6210710 Sustained release polymer blend for pharmaceutical applications |
| 04/03/2001 | US6210709 Plant based starch having been modified to have gelatin like properties; and a paint ball formulation, drug, vitamin, perfume or bath product contained within the capsule. |
| 04/03/2001 | US6210708 Cationic virosomes as transfer system for genetic material |
| 04/03/2001 | US6210707 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 04/03/2001 | US6210705 Flexible, finite system wherein the methylphenidate is present in an amount sufficient to achieve substantially zero order kinetics for delivery to the skin or mucosa of a patient in need thereof over a period of time at least 10 hours. |
| 04/03/2001 | US6210699 Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
| 04/03/2001 | US6210698 Suppository composition |
| 04/03/2001 | US6210688 Use of polymers as film-forming barrier materials |
| 04/03/2001 | US6210687 Fat emulsion containing xanthine derivative |
| 04/03/2001 | US6210683 Stabilizers containing recombinant human serum albumin for live virus vaccines |
| 04/03/2001 | US6210672 Topical immunostimulation to induce Langerhans cell migration |
| 04/03/2001 | US6210656 Self-foaming cream |
| 04/03/2001 | US6210343 Use of misoprostol or/and misoprostol acid for diagnosis of vascular damage in a subject with erectile dysfunction |
| 04/03/2001 | CA2285852C Pharmaceutical tablet comprising lisinopril disodium and microcrystalline cellulose |
| 04/03/2001 | CA2210996C Liquid formulations for proteinic pharmaceuticals |
| 04/03/2001 | CA2210823C Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration |
| 04/03/2001 | CA2169729C Water-soluble pressure-sensitive mucoadhesive |
| 04/03/2001 | CA2074186C Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 04/03/2001 | CA2053913C Microspheres for the controlled release of water-soluble substances and process for preparing them |
| 03/30/2001 | CA2321321A1 Polymers loaded with bioactive agents |
| 03/29/2001 | WO2001022087A1 Marking of products with electroactive compounds |
| 03/29/2001 | WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021297A1 Polydisperse double emulsion, corresponding monodisperse double emulsion and method for preparing the monodisperse emulsion |
| 03/29/2001 | WO2001021259A2 Use and compositions for treating platelet-related disorders using anagrelide |
| 03/29/2001 | WO2001021251A1 Implantable vascular access device |
| 03/29/2001 | WO2001021250A1 Container for receiving a pharmaceutical agent which acts upon or via the skin |
| 03/29/2001 | WO2001021212A1 A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes |
| 03/29/2001 | WO2001021211A2 Process for lessening polymorphic conversion of a drug |
| 03/29/2001 | WO2001021210A1 Anionic amino acid based surfactants to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 03/29/2001 | WO2001021209A1 Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 03/29/2001 | WO2001021207A2 Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| 03/29/2001 | WO2001021189A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| 03/29/2001 | WO2001021187A1 Process for producing protein powder |
| 03/29/2001 | WO2001021179A1 Quetiapine granules |
| 03/29/2001 | WO2001021178A2 Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs |
| 03/29/2001 | WO2001021175A1 Antibacterial medicinal compositions |
| 03/29/2001 | WO2001021174A1 Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles |
| 03/29/2001 | WO2001021171A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 03/29/2001 | WO2001021170A1 Systems for delivering anti-infective compositions from frangible ampules to treat disordered tissue such as cold sores |
| 03/29/2001 | WO2001021168A1 A process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
| 03/29/2001 | WO2001021163A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 03/29/2001 | WO2001021159A2 Pharmaceutical composition of nateglinide and another antidiabetcagent |
| 03/29/2001 | WO2001021156A1 Pharmaceutical chewing gum formulations |
| 03/29/2001 | WO2001021155A1 Cushioning wax beads for making solid shaped articles |
| 03/29/2001 | WO2001021154A2 Surface modified particulate compositions of biologically active substances |
| 03/29/2001 | WO2001021153A2 Pharmaceutical gel containing active substances |
| 03/29/2001 | WO2001021152A1 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 03/29/2001 | WO2001021151A1 Intranasal influenza virus vaccine |
| 03/29/2001 | WO2001021147A1 Diet and weight control gum and sucker |
| 03/29/2001 | WO2001021008A2 Method for increasing pet activity |
| 03/29/2001 | WO2001020991A1 Phytochemicals for promoting weight loss |
| 03/29/2001 | WO2001020990A1 Phytochemicals for treatment of mastalgia and endometriosis |
| 03/29/2001 | WO2001020981A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 03/29/2001 | WO2001020969A2 Use of ribose to prevent cramping and soreness in muscles |
| 03/29/2001 | WO2001007067A3 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 03/29/2001 | WO2001007049A3 Ophthalmic composition comprising ketotifen |
| 03/29/2001 | WO2001001923A3 Composition based on fluorinated polymer and alpha-hydroxy-acid salt for topical use for skin protection |
| 03/29/2001 | WO2000078294A3 Oral administration form for administering a fixed tramadol and diclofenac combination |
| 03/29/2001 | WO2000044386A8 Method for treatment of headache |
| 03/29/2001 | WO2000032255A9 Polymeric coatings with controlled delivery of active agents |
| 03/29/2001 | DE19946184A1 Retinoid-containing emulsions with continuous water phase, for topical application e.g. for skin treatment, repair or renewal, having structured, polar, viscous oil phase to stabilize active agent |
| 03/29/2001 | DE19945982A1 Geschwindigkeitsbestimmte Partikel Certain particle velocity |
| 03/29/2001 | DE19945283A1 Zubereitungen vom Emulsionstyp Wasser-in-Öl mit einem Gehalt an einem oder mehreren Siliconölen sowie einem oder mehreren kationischen Polymeren Preparations emulsion-type water-in-oil containing one or more silicone oils and one or more cationic polymers |
| 03/29/2001 | DE19944715A1 Ethereal oil mixture containing eucalyptus, pine needle and dwarf pine oils and menthol in isopropanol, useful as an inhalant or sauna additive |
| 03/29/2001 | DE19944262A1 Pharmazeutische Zusammensetzung in Form eines Nukleinsäure-Lipid-Komplexes, ihre Herstellung und Verwendung in der Gentherapie A pharmaceutical composition in the form of a nucleic acid-lipid complex, its preparation and use in gene therapy |
| 03/29/2001 | CA2391976A1 Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 03/29/2001 | CA2384829A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 03/29/2001 | CA2383589A1 Anionic amino acid based surfactants to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 03/29/2001 | CA2383413A1 Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| 03/29/2001 | CA2383144A1 Process for producing protein powder |
| 03/29/2001 | CA2383131A1 Formulation |
| 03/29/2001 | CA2383110A1 Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one non-ionic surfactant |
| 03/29/2001 | CA2382834A1 Process for lessening polymorphic conversion of a drug |
| 03/29/2001 | CA2382547A1 Methods and compositions for treating platelet-related disosders |
| 03/29/2001 | CA2377525A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| 03/29/2001 | CA2369515A1 Pharmaceutical chewing gum formulations |
| 03/29/2001 | CA2351673A1 Pharmaceutical antibacterial compositions |
| 03/28/2001 | EP1087009A2 Pellet compositions |
| 03/28/2001 | EP1086706A1 Stabilized compositions containing nootropic drugs |
| 03/28/2001 | EP1086702A2 Method for reduction of headache pain |
| 03/28/2001 | EP1086701A2 Simethicone containing laxative composition |
| 03/28/2001 | EP1086700A2 A solid pharmaceutical composition for dialysate containing sodium bicarbonate and a process for producing the same |
| 03/28/2001 | EP1086699A1 Process for producing composite preparation containing nucleic acid |
| 03/28/2001 | EP1086698A1 Agents for relieving side effects of adrenal cortex hormone |
| 03/28/2001 | EP1086697A2 New combination of formoterol and budesonide |
| 03/28/2001 | EP1086694A2 Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound |
| 03/28/2001 | EP1086691A1 Lozenge for providing carbohydrates with prolonged effect |
| 03/28/2001 | EP1086690A2 Pharmaceutical formulations of cefaclor |
| 03/28/2001 | EP1086689A2 Pharmaceutical formulations of cefaclor |
| 03/28/2001 | EP1086688A1 Suspension aerosol formulations |
| 03/28/2001 | EP1086687A2 Compositions of the type water-in-oil emulsion containing one or more silicone oil and one ore more cationic polymer |
| 03/28/2001 | EP1086683A1 Gel composition and its use in cosmetic compositions and the like |
| 03/28/2001 | EP1086524A1 Chuck apparatus for clamping a planar substrate in an electrostatic coating method |
| 03/28/2001 | EP1086239A1 Formulations for electroporation |
| 03/28/2001 | EP1086214A1 Microneedle devices and methods of manufacture and use thereof |
| 03/28/2001 | EP1086141A1 Aloe pectins |